BRAF-V600Eexpression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRAF-V600Eexpression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 211, Issue 4, Pages 669-683
Publisher
Rockefeller University Press
Online
2014-03-18
DOI
10.1084/jem.20130977
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Rapid Detection and Quantitation ofBRAFMutations in Hairy Cell Leukemia Using a Sensitive Pyrosequencing Assay
- (2012) Shalini Verma et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia
- (2012) S. Schnittger et al. BLOOD
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
- (2012) J. Haroche et al. BLOOD
- High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
- (2012) J. Haroche et al. BLOOD
- BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
- (2012) F. Sahm et al. BLOOD
- Identification of the V600D mutation in Exon 15 of theBRAFoncogene in congenital, benign langerhans cell histiocytosis
- (2012) Rina Kansal et al. GENES CHROMOSOMES & CANCER
- B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease
- (2012) Takeshi Satoh et al. PLoS One
- Conditional Deletion of TGF-βR1 Using Langerin-Cre Mice Results in Langerhans Cell Deficiency and Reduced Contact Hypersensitivity
- (2011) Sonja P. Zahner et al. JOURNAL OF IMMUNOLOGY
- Presence of Erdheim-Chester Disease and Langerhans Cell Histiocytosis in the Same Patient: A Report of 2 Cases
- (2011) Stacy L Pineles et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- (2010) G. Badalian-Very et al. BLOOD
- Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells
- (2010) C. E. Allen et al. JOURNAL OF IMMUNOLOGY
- Lack of Retinoic Acid Leads to Increased Langerin-Expressing Dendritic Cells in Gut-Associated Lymphoid Tissues
- (2009) Sun–Young Chang et al. GASTROENTEROLOGY
- Clofarabine in refractory Langerhans cell histiocytosis
- (2008) Carlos Rodriguez-Galindo et al. PEDIATRIC BLOOD & CANCER
- Treatment of juvenile xanthogranuloma
- (2008) Daniel G. Stover et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search